source
- Medicare $2,000 out-of-pocket cap boosts use of high-cost drugs, study showsA recent study published in JAMA Health Forum examined how the Inflation Reduction Act’s $2,000 annual out-of-pocket limit for Medicare beneficiaries affected drug consumption. The analysis found…
- CMS recalculates 2026 Medicare Advantage star ratings, increasing program volatility and affecting $16 billion in bonusesFederal officials have issued a new memo that recalculates the quality ratings for 2026 Medicare Advantage plans. The change follows another lawsuit from insurers that contest lower star ratings,…